Therapy and drug resistance at EACR 2027

Jun 14–17, 2027 Bilbao, Spain ~2.4k attendees Website

19 organizations at EACR 2027 present work in cancer therapy, drug resistance and persister cells, led by universities and institutes. Between them they bring 29 presentations to the program. Most represented: Gustave Roussy, Institute for Research in Biomedicine (IRB Barcelona) and Spanish National Cancer Research Centre (CNIO). As of Oct 13, 2026.

All 104 organizations at EACR 2027 →

Showing 1–16 of 19 organizations

Organization	EACR 2027 Attendance
Gustave Roussy Villejuif, France
gustaveroussy.fr Cancer centres & hospitals Cancer hospital and research centre in Villejuif, near Paris, affiliated with Paris-Saclay University.	Talk Tue Jun 15 9:20–10:55am Part of Joint EACR-ASEICA Symposium: Cancer initiation Title to be announced Cancer biology Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Epigenetics and RNA regulation in cancer Harnessing genetic and epitranscriptomic vulnerabilities in cancer: ADAR1 targeting as a new therapeutic opportunity Genomics · Therapy & resistance Talk Tue Jun 15 5:30–6:15pm Part of Keynote Lecture Title to be announced
Institute for Research in Biomedicine (IRB Barcelona) Barcelona, Spain
irbbarcelona.org Universities & institutes Biomedical research institute in Barcelona, Spain, with research programmes that include cancer science.	Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Paediatric cancers Mapping tumour heterogeneity to reveal novel treatment opportunities in childhood cancer Paediatric · Genomics Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Cancer ecosystems in space, time and therapy Title to be announced Immunology · Therapy & resistance Talk Wed Jun 16 11:35am–1:10pm Part of Symposium: Cancer evolution, somatic mutation, and early detection Cancer driver mutations in normal tissues and its relation to cancer risk Genomics · Prevention & detection
Spanish National Cancer Research Centre (CNIO) Madrid, Spain
cnio.es Universities & institutes Spain's public cancer research centre, with basic research, translational programmes and an experimental therapeutics programme.	Talk Tue Jun 15 3:20–4:55pm Part of Symposium: Cancer and extrinsic influences Timely Programs in the Tumor Microenvironment of Lung Cancers Immunology Talk Wed Jun 16 9:20–10:55am Part of Symposium: Signalling and cancer Title to be announced Cancer biology Talk Thu Jun 17 9:45–11am Part of EACR-ESMO bench to bedside Plenary Session: Precision targeting of RAS-driven cancers - New biology, new therapies A triple therapy to target pancreatic cancer Therapy & resistance
Memorial Sloan Kettering Cancer Center New York, NY
mskcc.org Cancer centres & hospitals NCI-designated comprehensive cancer centre in New York City for cancer care and research.	Talk Mon Jun 14 2:25–2:50pm Part of Joint EACR-EACS-Molecular Oncology Session: Latest advances in cancer immune-based therapies Title to be announced Immunology Plenary Mon Jun 14 3:50–6:15pm Part of EACR 2027 Congress - Opening Session Opening Keynote Lecture: Targeting Dormant Metastasis Cancer biology · Therapy & resistance
Research Institute of Molecular Pathology (IMP) Vienna, Austria
imp.ac.at Universities & institutes Basic biomedical research institute at the Vienna BioCenter in Austria, largely funded by Boehringer Ingelheim.	Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Next generation pre-clinical models Decoding tumor dependencies through in-vivo CRISPR screens Models · Genomics Talk Tue Jun 15 3:20–4:55pm Part of Symposium: Cancer plasticity, metastasis, and therapy resistance Title to be announced Cancer biology · Therapy & resistance
Stanford University Stanford, CA
stanford.edu Universities & institutes Private research university in Stanford, California, with a school of medicine.	Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Cancer ecosystems in space, time and therapy Title to be announced Immunology · Therapy & resistance Plenary Thu Jun 17 12:05–1pm Keynote Lecture & Closing Remarks
University of Turin Turin, Italy
unito.it Universities & institutes Public university in Turin, Italy.	Talk Wed Jun 16 3:20–4:55pm Part of Joint EACR-EMBO Symposium: Persister Cells Targeted therapy-induced genomic instability reveals synthetic lethal DDR vulnerabilities in colorectal cancer Therapy & resistance · Genomics Session Wed Jun 16 5:30–6:30pm Meet the Editors Panel
Vall d'Hebron Institute of Oncology (VHIO) Barcelona, Spain
vhio.net Cancer centres & hospitals Translational cancer research institute on the campus of Vall d'Hebron University Hospital in Barcelona, Spain.	Talk Wed Jun 16 11:35am–1:10pm Part of Symposium: Immunotherapy advances and predicting response Title to be announced Immunology Talk Wed Jun 16 3:20–4:55pm Part of Symposium: Revisiting MYC Bringing the first clinically viable MYC inhibitor to the bedside Therapy & resistance
University College London (UCL) London, UK
ucl.ac.uk Universities & institutes Public research university in London, home to the UCL Cancer Institute.	Talk Wed Jun 16 9:20–10:55am Part of Symposium: Signalling and cancer Pharmacological activation of PI3Kα induces cancer cell death under metabolic stress Cancer biology · Therapy & resistance
Ludwig Institute for Cancer Research New York, NY
ludwigcancerresearch.org Universities & institutes International cancer research organisation running research branches and Ludwig Centers at universities in Europe and the United States.	Session Mon Jun 14 3:45–6:15pm EACR 2027 Congress - Opening Session Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Cancer ecosystems in space, time and therapy Title to be announced Immunology · Therapy & resistance
KRAS Kickers Charlotte, NC
kraskickers.org Societies, charities & agencies Patient-led nonprofit offering education, research updates, advocacy and support for people with KRAS-mutant cancers.	Talk Thu Jun 17 9:45–11am Part of EACR-ESMO bench to bedside Plenary Session: Precision targeting of RAS-driven cancers - New biology, new therapies Walking the RAS Pathway From Pipeline to Patient Impact Therapy & resistance
NYU Langone Health New York, NY
nyulangone.org Cancer centres & hospitals Academic medical center and health system based in New York City.	Talk Tue Jun 15 3:20–4:55pm Part of Symposium: Oncogenic signaling beyond cancer Targeting PI3K in overgrowth syndromes Cancer biology · Therapy & resistance
Sanofi Paris, France
sanofi.com Pharma Global pharmaceutical company headquartered in Paris, developing medicines and vaccines.	Talk Tue Jun 15 11:35am–1:10pm Part of Symposium: Paediatric cancers Bridging the Gap: From Discovery to Delivery in Childhood Cancer Therapeutics Paediatric · Therapy & resistance
Sarah Cannon Research Institute Nashville, TN
scri.com CROs & services Oncology research organisation running cancer clinical trials across a network of community sites.	Talk Thu Jun 17 9:45–11am Part of EACR-ESMO bench to bedside Plenary Session: Precision targeting of RAS-driven cancers - New biology, new therapies Title to be announced Therapy & resistance
Tel Aviv University Tel Aviv, Israel
tau.ac.il Universities & institutes Public research university in Tel Aviv, Israel.	Talk Wed Jun 16 3:20–4:55pm Part of Joint EACR-EMBO Symposium: Persister Cells The day after the drug: investigating persister cell memory Therapy & resistance
University of Helsinki Helsinki, Finland
helsinki.fi Universities & institutes Public research university in Helsinki, Finland.	Talk Tue Jun 15 3:20–4:55pm Part of Symposium: Cancer plasticity, metastasis, and therapy resistance Decoding Chemotherapy Resistance in Ovarian Cancer Therapy & resistance